Non-Current Assets
CVS Health·Balance Sheet Statement·13 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $252.5B | $252.4B | $253.2B | $255.6B | $258.3B | $255.3B | $253.5B | $253B |
| Goodwill | $91.3B | $91.3B | $91.3B | $91.2B | $91.2B | $85.5B | $85.5B | $85.5B |
| Investments | $28.8B | $31.7B | $31.3B | $31.5B | $32.2B | $33.7B | $34.8B | $34.7B |
| Investments | $25B | $28.9B | $28.9B | $28.9B | $29.9B | $31.6B | $32.7B | $32.4B |
| Other intangible assets—net | $28.3B | $27.8B | $27.3B | $26.6B | $26.2B | $26B | $25.5B | $25.1B |
| Operating lease right-of-use assets | $16.9B | $16.2B | $15.9B | $15.7B | $15.5B | $15.3B | $15B | $14.7B |
| Operating Lease Right-of-Use Assets in Other Assets | $16.9B | $16.2B | $15.9B | $15.7B | $15.5B | $15.3B | $15B | $14.7B |
| Property, plant and equipment, net | $13B | $12.7B | $13B | $12.9B | $12.8B | $12.8B | $13.1B | $13B |
| Deferred Tax Assets and Other Non-Current Assets | $4.8B | $4.8B | $4.8B | $5.2B | $5.2B | $5.2B | $7.1B | $7.4B |
| Other non-current assets | $4.8B | $4.8B | $4.8B | $5.2B | $5.2B | $5.2B | $7.1B | $7.4B |
| Software and Technology Licenses, Net | $4.8B | $4.8B | $4.8B | $5.2B | $5.2B | $5.2B | $7.1B | $7.4B |
| Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84) | $3.8B | $2.8B | $2.4B | $2.6B | $2.4B | $2.1B | $2.1B | $2.3B |
| Equity securities | — | — | — | — | — | — | $333M | $410M |